Semaglutide Semaglutide activates the GLP-1 receptor and may help eligible patients manage appetite, food intake, blood-sugar response, and body weight as part of a physician-guided program
If your levothyroxine dose is too low and you feel persistently fatigued, that may slow your progress with weight loss in general, but not because of any direct interaction
Shifting the dose time or splitting doses is a clinical decision and should be guided by pattern analysis and professional advice
Current evidence strongly supports the safety of GLP-1 medications regarding thyroid cancer risk when used appropriately
Our results are consistent with those reported in previous studies demonstrating that GLP-1 agonists prevent excessive ECM degradation by suppressing cardiac fibroblast activity 61,62
Weight-Related Health Conditions: Such as hypertension, dyslipidemia, or type 2 diabetes